Cytomegalovirus infection after liver transplantation incidence, risks, and benefits of prophylaxis
Cytomegalovirus (CMV) infection and related disease is a feared complication after liver transplantation. Antiviral prophylaxis is recommended in clinical practice guidelines depending on the CMV status of both donor and recipient as well as the individual risk profile.
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
9 September 2010
|
| In: |
Transplantation proceedings
Year: 2010, Volume: 42, Issue: 7, Pages: 2634-2641 |
| ISSN: | 1873-2623 |
| DOI: | 10.1016/j.transproceed.2010.04.025 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.transproceed.2010.04.025 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0041134510008857 |
| Author Notes: | K. Weigand, P. Schnitzler, J. Schmidt, F. Chahoud, D. Gotthardt, P. Schemmer, W. Stremmel, and P. Sauer |
| Summary: | Cytomegalovirus (CMV) infection and related disease is a feared complication after liver transplantation. Antiviral prophylaxis is recommended in clinical practice guidelines depending on the CMV status of both donor and recipient as well as the individual risk profile. |
|---|---|
| Item Description: | Gesehen am 18.10.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1873-2623 |
| DOI: | 10.1016/j.transproceed.2010.04.025 |